DGCI approves market authorisation of Serum Institute's Covovax as booster dose

Jan 17, 2023

This vaccine can be taken as a booster dose by people who have already taken two doses of Covishield or Covaxin.

India to procure 27-28 crore COVID-19 vaccine doses in October: Sources

Sep 30, 2021

New Delhi [India], September 30 : India would have 27-28 crore COVID-19 vaccine doses of Serum Institute of India's Covishield and Bharat Biotech's Covaxin...

There is no choice between vaccines, says Karnataka Health Minister over KARD's objection to Covaxin

Jan 19, 2021

Bengaluru (Karnataka) [India], January 19 : After the Karnataka Association of Resident Doctors' objected to taking the Covaxin shot developed by Hyderabad-based Bharat Biotech...

Delhi receives fresh COVID-19 vaccine stock from Centre for 45+

May 29, 2021

New Delhi [India], May 29 : Delhi received a fresh stock of COVID-19 vaccine that includes 48,890 doses of Covaxin and 83,970 doses of...

Regular market approval to Covishield, Covaxin expected soon after final price fixation: Sources

Jan 26, 2022

New Delhi [India], January 26 : The regular market approval from Drugs Controller General of India (DCGI) to COVID-19 vaccine Covishield and Covaxin is...

DCGI recommends Covovax as heterologous booster dose

Jan 12, 2023

The Central drug regulatory authority Drugs Controller General of India (DCGI) has recommended market authorisation for Serum Institute of India's Covid vaccine Covovax as...